An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells-Reference-Cited by-同舟云学术

An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells

Published:2009-02-01 Issue:3 Volume:124 Page:622-629
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Dewan Md. Zahidunnabi,Tomita Mariko,Katano Harutaka,Yamamoto Norio,Ahmed Sunjida,Yamamoto Michiko,Sata Tetsutaro,Mori Naoki,Yamamoto Naoki

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference35 articles.

1. Presence of EB virus nucleic acid homology in a “virus-free” line of Burkitt tumour cells;Zur Hausen;Nature,1970

2. Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics;Nonoyama;Nature,1973

3. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes;Rowe;J Virol,1992

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review;Clinical Complementary Medicine and Pharmacology;2022-12

2. From Innate Immunity to Inflammation: A Primer on Multiple Facets of NF-κB Signaling in COVID-19;Physiologia;2022-06-17

3. COVID-19 and the role of cytokines in this disease;Inflammopharmacology;2022-05-04

4. The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease;Molecular Neurobiology;2021-06-01

5. The immuno-oncological challenge of COVID-19;Nature Cancer;2020-10